MetLife Investment Management, LLC - GENMARK DIAGNOSTICS INC ownership

Back to all holdings Add to watchlist

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 98 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$595,277
+32.6%
24,907
-19.0%
0.01%
+20.0%
Q4 2020$449,038
+2.8%
30,7560.0%0.01%0.0%
Q3 2020$436,735
-3.5%
30,7560.0%0.01%0.0%
Q2 2020$452,421
+316.7%
30,756
+16.7%
0.01%
+150.0%
Q1 2020$108,562
-14.3%
26,3500.0%0.00%
+100.0%
Q4 2019$126,744
-20.6%
26,3500.0%0.00%
-50.0%
Q3 2019$159,681
-6.6%
26,3500.0%0.00%0.0%
Q2 2019$171,012
-8.5%
26,3500.0%0.00%0.0%
Q1 2019$186,822
+45.9%
26,3500.0%0.00%0.0%
Q4 2018$128,061
-33.9%
26,3500.0%0.00%0.0%
Q3 2018$193,673
+15.3%
26,3500.0%0.00%0.0%
Q2 2018$168,000
+17.5%
26,3500.0%0.00%0.0%
Q1 2018$143,000–26,350–0.00%–
 Download
Other shareholders

There were no reported owners of GENMARK DIAGNOSTICS INC in Q1 2018.

NameSharesValueWeighting ↓
View complete list of GENMARK DIAGNOSTICS INC shareholders